MDGL - Madrigal Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

MDGL is currently covered by 12 analysts with an average price target of $523.76. This is a potential upside of $86.59 (19.81%) from yesterday's end of day stock price of $437.17.

Madrigal Pharmaceuticals's activity chart (see below) currently has 145 price targets and 135 ratings on display. The stock rating distribution of MDGL is 11.11% HOLD, 86.67% BUY and 2.22% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 89.21% with an average time for these price targets to be met of 467 days.

Highest price target for MDGL is $523, Lowest price target is $392, average price target is $434.91.

Most recent stock forecast was given by JONATHAN WOLLEBEN from JMP on 20-Aug-2025. First documented stock forecast 29-Oct-2014.

Currently out of the existing stock ratings of MDGL, 5 are a HOLD (11.11%), 39 are a BUY (86.67%), 1 are a SELL (2.22%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$485

$70.32 (16.96%)

$443

8 days ago
(20-Aug-2025)

11/14 (78.57%)

$93.34 (23.83%)

449

Buy

$523

$108.32 (26.12%)

$441

16 days ago
(12-Aug-2025)

2/4 (50%)

$164 (45.68%)

605

Buy

$428

$13.32 (3.21%)

$420

22 days ago
(06-Aug-2025)

12/14 (85.71%)

$89.89 (26.59%)

429

Buy

$460

$45.32 (10.93%)

$422

3 months 26 days ago
(02-May-2025)

10/14 (71.43%)

$144.52 (45.81%)

261

Buy

$405

$-9.68 (-2.33%)

$400

6 months 1 days ago
(27-Feb-2025)

18/18 (100%)

$49.12 (13.80%)

287

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is MDGL (Madrigal Pharmaceuticals) average time for price targets to be met?

On average it took 467 days on average for the stock forecasts to be realized with a an average price target met ratio 89.21

Which analyst has the current highest performing score on MDGL (Madrigal Pharmaceuticals) with a proven track record?

JONATHAN WOLLEBEN

Which analyst has the most public recommendations on MDGL (Madrigal Pharmaceuticals)?

Jonathan Wolleben works at JMP and has 10 price targets and 8 ratings on MDGL

Which analyst is the currently most bullish on MDGL (Madrigal Pharmaceuticals)?

Andrea Tan with highest potential upside - $150.32

Which analyst is the currently most reserved on MDGL (Madrigal Pharmaceuticals)?

Matthew Luchini with lowest potential downside - -$303.68

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?